Apyx Medical receives expanded FDA clearance for AYON Body Contouring System to include power liposuction
APYX has more than doubled off its 52-week low of $1.08.
Summary
Apyx Medical announced expanded FDA 510(k) clearance for its AYON Body Contouring System to include power liposuction, enhancing the system's capabilities and market potential.
Key Events · Product Development and Regulatory · APYX
-
Expanded FDA Clearance
Apyx Medical received expanded 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its AYON Body Contouring System to include power liposuction.
-
Enhanced Product Offering
The addition of power liposuction, an advanced modality, is expected to enhance the system's efficiency in fat removal, reduce surgeon effort, and streamline operating room time, making AYON a more comprehensive solution.
-
Strategic Commercialization
The company plans a limited commercial launch of the power liposuction function to refine training, utilization, and customer experience before scaling broader commercial adoption.
Analysis · APYX · Industrial Applications And Services
This expanded FDA clearance for the AYON Body Contouring System to include power liposuction is a significant positive development for Apyx Medical. It enhances the capabilities of a key product, making it more versatile and efficient for surgeons. This could drive increased adoption and market demand for AYON, contributing to revenue growth and building on the company's recent strong financial performance. The planned limited commercial launch indicates the company is ready to capitalize on this new approval.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, APYX was trading at $3.78 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $153.7M. The 52-week trading range was $1.08 to $4.50. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.